insights_auto
Why is PRQR down 5.04%?
Dive Deeperchevron_right
PRQR:NASDAQ
ProQR Therapeutics NV
$1.32
arrow_downward
-5.04%(-0.070) 1D
$1.35
arrow_upward
+2.27% (+0.030)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRQR...
Open
$1.39
High
$1.45
Low
$1.30
Mkt. cap
186.28M
Avg. vol.
882.39K
Volume
23.00
52-wk high
$2.81
52-wk low
$1.20
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
Open
$1.39
High
$1.45
Low
$1.30
Mkt. cap
186.28M
Avg. vol.
882.39K
Volume
23.00
52-wk high
$2.81
52-wk low
$1.20
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
News stories
From web sources and news partners
The Motley Fool
·
14 minutes ago
The Stock Market Will Make a Big Move in the Next 6 Months if History Repeats Itself
ChartMill
·
41 minutes ago
Acadia Healthcare (NASDAQ:ACHC) Meets a Breakout Setup With Strong Technicals
Yahoo Finance
·
1 hour ago
Broadridge Signs On to Run Shareholder Votes for NYSE’s Planned Tokenized Stocks
Seeking Alpha
·
3 hours ago
The Midterm Election Rally: What 19 Election Cycles Reveal About the S&P 500
Profile
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
About ProQR Therapeutics NV